Pacific GeneTech
PrivateLast Round
Series A
Aug 24, 2022
Total Funding Raised
$10M
Company Overview
Pacific GeneTech operates in Healthcare & Life Sciences and is based in Rogers, Arkansas. Its latest recorded funding round was a Series A round in August 2022.
Pacific GeneTech is a biotechnology company that develops and commercializes next-generation vaccines and adjuvant technologies for animal health and food safety.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pacific GeneTech Comparables
Compare Pacific GeneTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endovac Animal Health | 78% | |
| Aptimmune Biologics, Inc. | 77% | |
| Biogénesis Bagó | 68% |
For institutional investors. Book with your work email.
Pacific GeneTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 24, 2022 | ||||
| Early Funding | May 24, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pacific GeneTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AVG Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors grew 105% MoM.
- Jan 26, 2026
Monthly visitors grew 121% MoM, reaching 1K.
For institutional investors. Book with your work email.
Pacific GeneTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pacific GeneTech's valuation, stock price, and market status.
Is Pacific GeneTech a public or private company?
Pacific GeneTech is a private company.
What is the current stock price of Pacific GeneTech?
Pacific GeneTech is a private company, so its shares have no public market price. Caplight tracks Pacific GeneTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pacific GeneTech worth (valuation)?
Valuation information for Pacific GeneTech is not publicly available.
Can I buy Pacific GeneTech stock?
Pacific GeneTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pacific GeneTech's last funding round?
Pacific GeneTech's most recent funding round was Series A on August 24, 2022.
Who are the main investors in Pacific GeneTech?
Key investors in Pacific GeneTech include AVG Ventures.
Will Pacific GeneTech IPO soon?
No public IPO plans have been announced for Pacific GeneTech.
How can I track Pacific GeneTech secondary market activity?
Caplight tracks bids, offers, and trades in Pacific GeneTech's shares on secondary markets.